Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications

Item

http://www.wikidata.org/entity/Q37050954

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 December 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Association of Medicare Part D ...... lization of statin medications

@en

Association of Medicare Part D ...... ization of statin medications.

@nl

type

Item

label

Association of Medicare Part D ...... lization of statin medications

@en

Association of Medicare Part D ...... ization of statin medications.

@nl

prefLabel

Association of Medicare Part D ...... lization of statin medications

@en

Association of Medicare Part D ...... ization of statin medications.

@nl

P1476

Association of Medicare Part D ...... lization of statin medications

@en

P2093

Jean M Abraham

http://www.w3.org/2001/XMLSchema#string

Pinar Karaca-Mandic

http://www.w3.org/2001/XMLSchema#string

Robert L Kane

http://www.w3.org/2001/XMLSchema#string

Tami Swenson

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of the coverage gap on drug spending: a closer look at Medicare Part D

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population.

Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

P304

1311-1333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1475-6773.12022

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23278369

http://www.w3.org/2001/XMLSchema#string

P932

3725527

http://www.w3.org/2001/XMLSchema#string